Search Results - Baldobí, F.

Long-Term Prognosis of HIV-Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubicin by Martín-Carbonero, L., Palacios, R., Valencia, E., Saballs, P., Sirera, G., Santos, I., Baldobí, F., Alegre, M., Goyenechea, A., Pedreira, J., González del Castillo, J., Martínez-Lacasa, J., Ocampo, A., Alsina, M., Santos, J., Podzamczer, D., González-Lahoz, J.

“…Introduction. Incidence of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)-infected persons has dramatically decreased in the highly active…”
Get full text

Long-Term Prognosis of HIV-Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubidn by Martín-Carbonero, L., Palacios, R., Valencia, E., Saballs, P., Sirera, G., Santos, I., Baldobí, F., Alegre, M., Goyenechea, A., Pedreira, J., del Castillo, J. González, Martínez-Lacasa, J., Ocampo, A., Alsina, M., Santos, J., Podzamczer, D., González-Lahoz, J.

“…Introduction. Incidence of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)-infected persons has dramatically decreased in the highly active…”
Get full text

Long-Term Prognosis of HIV-Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubicin. Commentary by MARTIN-CARBONERO, L, PALACIOS, R, GONZALEZ DEL CASTILLO, J, MARTINEZ-LACASA, J, OCAMPO, A, ALSINA, M, SANTOS, J, PODZAMCZER, D, GONZALEZ-LAHOZ, J, DUPIN, N, DEL GIUDICE, P, VALENCIA, E, SABALLS, P, SIRERA, G, SANTOS, I, BALDOBI, F, ALEGRE, M, GOYENECHEA, A, PEDREIRA, J

Get full text